Immunology and immunotherapy in breast cancer

Immuno-oncology is a rapidly developing field in medicine. Drug combination therapies have already been studied in many clinical trials on various tumor types. In recent years, a checkpoint inhibition therapy with monoclonal antibodies targeting PD-1 and its ligand PD-L1 has been developed. Breast c...

Descripción completa

Detalles Bibliográficos
Autores principales: Semiglazov, Vladimir, Tseluiko, Andrey, Kudaybergenova, Asel, Artemyeva, Anna, Krivorotko, Petr, Donskih, Roman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Compuscript 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9196061/
https://www.ncbi.nlm.nih.gov/pubmed/35676750
http://dx.doi.org/10.20892/j.issn.2095-3941.2021.0597

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9196061/
https://www.ncbi.nlm.nih.gov/pubmed/35676750
http://dx.doi.org/10.20892/j.issn.2095-3941.2021.0597

Ejemplares similares